Published in Toxicol Lett on December 01, 1992
Sex differences in the acquisition of IV methamphetamine self-administration and subsequent maintenance under a progressive ratio schedule in rats. Psychopharmacology (Berl) (2003) 1.50
Age and sex differences in the locomotor effect of repeated methylphenidate in rats classified as high or low novelty responders. Psychopharmacology (Berl) (2006) 0.95
Role of biotransformation in 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione-induced hepatotoxicity in Fischer 344 rats. Toxicology (2008) 0.83
Bioactivation of nevirapine to a reactive quinone methide: implications for liver injury. Chem Res Toxicol (2012) 0.80
Pharmacokinetic and pharmacodynamic interactions between dehydroepiandrosterone and prednisolone in the rat. Drug Metabol Drug Interact (1999) 0.79
Disposition and toxicity of trabectedin (ET-743) in wild-type and mdr1 gene (P-gp) knock-out mice. Invest New Drugs (2009) 0.79
Oestrogen enhances cardiotoxicity induced by Sunitinib by regulation of drug transport and metabolism. Cardiovasc Res (2015) 0.77
3-Methylcholanthrene (3-MC) and 4-chlorobiphenyl (PCB3) genotoxicity is gender-related in Fischer 344 transgenic rats. Environ Int (2010) 0.76
Metabolism and pharmacokinetics of the anti-tuberculosis drug ethionamide in a flavin-containing monooxygenase null mouse. Pharmaceuticals (Basel) (2012) 0.76
Gonadal hormone modulation of ∆(9)-tetrahydrocannabinol-induced antinociception and metabolism in female versus male rats. Pharmacol Biochem Behav (2016) 0.75
A small-animal pharmacokinetic/pharmacodynamic PET study of central serotonin 1A receptor occupancy by a potential therapeutic agent for overactive bladder. PLoS One (2013) 0.75
Daikenchuto (TU-100) alters murine hepatic and intestinal drug metabolizing enzymes in an in vivo dietary model: effects of gender and withdrawal. Pharmacol Res Perspect (2017) 0.75
Toxicological evaluation of a novel umami flavour compound: 2-(((3-(2,3-Dimethoxyphenyl)-1H-1,2,4-triazol-5-yl)thio)methyl)pyridine. Toxicol Rep (2016) 0.75
Toxicological evaluation and metabolism of two N-alkyl benzamide umami flavour compounds: N-(heptan-4-yl)benzo[d][1,3]dioxole-5-carboxamide and (R)-N-(1-methoxy-4-methylpentan-2-yl)-3,4-dimethylbenzamide. Toxicol Rep (2016) 0.75
Toxicological evaluation of a novel cooling compound: 2-(4-methylphenoxy)-N-(1H-pyrazol-3-yl)-N-(2-thienylmethyl)acetamide. Toxicol Rep (2015) 0.75
[Radiological study of the accessory skeletal elements in the foot and ankle (author's transl)]. Nihon Seikeigeka Gakkai Zasshi (1981) 1.44
cDNA cloning of the hydroxysteroid sulfotransferase STa sharing a strong homology in amino acid sequence with the senescence marker protein SMP-2 in rat livers. Biochem Biophys Res Commun (1990) 1.37
Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity. Drug Metab Dispos (2000) 1.27
Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy. Cancer (1992) 1.15
Suppression of levels of phenobarbital-inducible rat liver cytochrome P-450 by pituitary hormone. J Biol Chem (1987) 1.15
Inhibition selectivity of grapefruit juice components on human cytochromes P450. Arch Biochem Biophys (2000) 1.06
Involvement of multiple human cytochromes P450 in the liver microsomal metabolism of astemizole and a comparison with terfenadine. Br J Clin Pharmacol (2001) 1.04
Inhibitory effect of natural furanocoumarins on human microsomal cytochrome P450 3A activity. Jpn J Pharmacol (2000) 1.01
Mechanism of 7,12-dimethylbenz[a]anthracene-induced immunotoxicity: role of metabolic activation at the target organ. Jpn J Pharmacol (2001) 0.96
Human CYP2C-mediated stereoselective phenytoin hydroxylation in Japanese: difference in chiral preference of CYP2C9 and CYP2C19. Biochem Pharmacol (1999) 0.95
Sex difference of cytochrome P-450 in the rat: purification, characterization, and quantitation of constitutive forms of cytochrome P-450 from liver microsomes of male and female rats. Arch Biochem Biophys (1983) 0.95
Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction. Pharmacogenetics (1997) 0.94
Expression of a human P-450IIC gene in yeast cells using galactose-inducible expression system. Mol Pharmacol (1989) 0.94
Cloning and sequence analysis of a rat liver cDNA encoding hydroxysteroid sulfotransferase. Biochem Biophys Res Commun (1989) 0.94
Mechanisms of retinoid resistance in leukemic cells: possible role of cytochrome P450 and P-glycoprotein. Blood (1996) 0.94
Microsomal activation of 2-amino-3-methylimidazo[4,5-f]quinoline, a pyrolysate of sardine and beef extracts, to a mutagenic intermediate. Cancer Res (1983) 0.93
Cytochrome b5 potentiation of cytochrome P-450 catalytic activity demonstrated by a vaccinia virus-mediated in situ reconstitution system. Proc Natl Acad Sci U S A (1990) 0.92
Nucleotide sequence of a full-length cDNA (PST-1) for aryl sulfotransferase from rat liver. Nucleic Acids Res (1990) 0.92
Genetic polymorphisms in human liver phenol sulfotransferases involved in the bioactivation of N-hydroxy derivatives of carcinogenic arylamines and heterocyclic amines. Chem Biol Interact (1998) 0.91
N-hydroxylation of carcinogenic and mutagenic aromatic amines. Environ Health Perspect (1983) 0.90
DNA binding by 1-nitropyrene and 1,6-dinitropyrene in vitro and in vivo: effects of nitroreductase induction. Carcinogenesis (1988) 0.89
Pharmacogenetics of sulfotransferase. Annu Rev Pharmacol Toxicol (2000) 0.89
Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice. Br J Clin Pharmacol (2000) 0.88
Isolation and characterization of a new major intestinal CYP3A form, CYP3A62, in the rat. J Pharmacol Exp Ther (2004) 0.86
Isolation and expression of a cDNA encoding a male-specific rat sulfotransferase that catalyzes activation of N-hydroxy-2-acetylaminofluorene. J Biol Chem (1993) 0.86
In vitro inhibition of human small intestinal and liver microsomal astemizole O-demethylation: different contribution of CYP2J2 in the small intestine and liver. Xenobiotica (2003) 0.86
Arachidonic acid-dependent peroxidative activation of carcinogenic arylamines by extrahepatic human tissue microsomes. Cancer Res (1989) 0.85
Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor. Br J Cancer (1997) 0.85
Metabolic activation and covalent binding to nucleic acids of carcinogenic heterocyclic amines from cooked foods and amino acid pyrolysates. Jpn J Cancer Res (1987) 0.85
Enhancement of Binding of N-Hydroxy-TRP-P-2 to DNA by seryl-tRNA synthetase. Biochem Biophys Res Commun (1981) 0.85
Grapefruit component interacting with rat and human P450 CYP3A: possible involvement of non-flavonoid components in drug interaction. Biol Pharm Bull (1997) 0.85
Mechanism of activation of proximate mutagens in Ames' tester strains: the acetyl-CoA dependent enzyme in Salmonella typhimurium TA98 deficient in TA98/1,8-DNP6 catalyzes DNA-binding as the cause of mutagenicity. Biochem Biophys Res Commun (1983) 0.84
Purification of human liver cytochrome P-450 catalyzing testosterone 6 beta-hydroxylation. J Biochem (1987) 0.84
A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Catalytic characterization and immunochemical quantitation in liver microsomes. Mol Pharmacol (1983) 0.84
Structure and expression of the rat CYP3A1 gene: isolation of the gene (P450/6betaB) and characterization of the recombinant protein. Arch Biochem Biophys (1999) 0.83
Transcriptional elements directing a liver-specific expression of P450/6 beta A (CYP3A2) gene-encoding testosterone 6 beta-hydroxylase. Arch Biochem Biophys (1995) 0.83
Polymorphism in hydroxylation of mephenytoin and hexobarbital stereoisomers in relation to hepatic P-450 human-2. Clin Pharmacol Ther (1990) 0.83
Isolation and characterization of active metabolites of tryptophan-pyrolysate mutagen, TRP-P-2, formed by rat liver microsomes. Chem Biol Interact (1980) 0.83
Effects of ascorbic acid on the nonenzymatic binding to DNA and the mutagenicity of N-hydroxylated metabolite of a tryptophan-pyrolysis product. Biochem Biophys Res Commun (1982) 0.82
High capacity of human skin for N-acetylation of arylamines. Skin Pharmacol (1990) 0.82
Amounts and variation in grapefruit juice of the main components causing grapefruit-drug interaction. J Chromatogr B Biomed Sci Appl (2000) 0.82
Metabolic activation of mutagenic tryptophan pyrolysis products by rat liver microsomes. Cancer Res (1980) 0.82
Metabolic activation of N-hydroxylated metabolites of carcinogenic and mutagenic arylamines and arylamides by esterification. Drug Metab Rev (1994) 0.82
Chemical carcinogenesis, mutagenesis, and teratogenesis. Can J Physiol Pharmacol (1996) 0.82
Cytochrome P450 mediated metabolism of diazepam in human and rat: involvement of human CYP2C in N-demethylation in the substrate concentration-dependent manner. Pharmacogenetics (1993) 0.82
Hepatic triiodothyronine sulfation and its regulation by growth hormone and triiodothyronine in rats. J Biochem (1992) 0.82
Decrease in the activity of hepatic microsomal drug-metabolizing enzymes in tumor-bearing nude mice. Gan (1982) 0.82
Sulfotransferase-mediated DNA binding of N-hydroxyarylamines(amide) in liver cytosols from human and experimental animals. Carcinogenesis (1992) 0.82
Activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b] pyridine by cDNA-expressed human and rat arylsulfotransferases. Jpn J Cancer Res (1994) 0.81
Lack of low Km diazepam N-demethylase in livers of poor metabolizers for S-mephenytoin 4'-hydroxylation. Pharmacogenetics (1994) 0.81
Purification of hepatic N-hydroxyarylamine sulfotransferases and their regulation by growth hormone and thyroid hormone in rats. J Biochem (1991) 0.81
Enzymatic characterization and interspecies difference of phenol sulfotransferases, ST1A forms. Drug Metab Dispos (2001) 0.81
Role for enhanced faecal excretion of bile acid in hydroxysteroid sulfotransferase-mediated protection against lithocholic acid-induced liver toxicity. Xenobiotica (2006) 0.81
The S-acetyl coenzyme A-dependent metabolic activation of the carcinogen N-hydroxy-2-aminofluorene by human liver cytosol and its relationship to the aromatic amine N-acetyltransferase phenotype. Carcinogenesis (1987) 0.81
Primary structures and properties of two related forms of aryl sulfotransferases in human liver. Pharmacogenetics (1995) 0.81
Nucleotide sequence of a human liver cytochrome P-450 related to the rat male specific form. J Biochem (1987) 0.81
Stereoselective oxidation and plasma protein binding of nilvadipine, a new dihydropyridine calcium antagonist, in man. Res Commun Chem Pathol Pharmacol (1988) 0.81
Evidence for the involvement of N-hydroxylation of 3-amino-1-methyl-5H-pyrido[4,3-b]indole by cytochrome P-450 in the covalent binding to DNA. Cancer Res (1981) 0.81
Soft-hydrothermal processing of red cedar bedding reduces its induction of cytochrome P450 in mouse liver. Lab Anim (2008) 0.81
Species difference in N-hydroxylation of a tryptophan pyrolysis product in relation to mutagenic activation. Cancer Res (1981) 0.81
Reactivity of benzidine diimine with DNA to form N-(deoxyguanosin-8-yl)-benzidine. Carcinogenesis (1986) 0.81
Identification of ST2A1 as a rat brain neurosteroid sulfotransferase mRNA. Brain Res (2001) 0.80
Properties of cutaneous acetyltransferase catalyzing N- and O-acetylation of carcinogenic arylamines and N-hydroxyarylamine. Biochem Pharmacol (1988) 0.80
Structural elucidation of a mutagenic metabolite of 3-amino-1-methyl-5H-pyrido[4,3-b]indole. Drug Metab Dispos (1981) 0.80
Inhibitory potential of herbal medicines on human cytochrome P450-mediated oxidation: properties of umbelliferous or citrus crude drugs and their relative prescriptions. Jpn J Pharmacol (2001) 0.80
cDNA and deduced amino acid sequences of human P450 IIA3 (CYP2A3). Nucleic Acids Res (1989) 0.80
Isolation and characterization of a new rat P450 (CYP3A18) cDNA encoding P450(6)beta-2 catalyzing testosterone 6 beta- and 16 alpha-hydroxylations. Pharmacogenetics (1996) 0.80
Role of growth hormone in modulating the constitutive and phenobarbital-induced levels of two P-450(6)beta (testosterone 6 beta-hydroxylase) mRNAs in rat livers. J Biochem (1989) 0.80
A gene structure of testosterone 6 beta-hydroxylase (P450IIIA). Biochem Biophys Res Commun (1991) 0.80
Formation of 2-amino-3-methylimidazo[4,5-f]quinoline- and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-sulfamates by cDNA-expressed mammalian phenol sulfotransferases. Jpn J Cancer Res (1995) 0.80
Activation and detoxication of N-hydroxy-Trp-P-2 by glutathione and glutathione transferases. Carcinogenesis (1983) 0.80
Species differences in stereoselective metabolism of mephenytoin by cytochrome P450 (CYP2C and CYP3A). J Pharmacol Exp Ther (1993) 0.79
An arylamine acetyltransferase (AT-I) from Syrian golden hamster liver: cloning, complete nucleotide sequence, and expression in mammalian cells. Mol Carcinog (1991) 0.79
Enzymatic characterization of human cytosolic sulfotransferases; identification of ST1B2 as a thyroid hormone sulfotransferase. Biol Pharm Bull (1999) 0.79
Further studies on the persistence of neonatal androgen imprinting on sex-specific cytochrome P-450, testosterone and drug oxidations. Jpn J Pharmacol (1987) 0.79
Effects of hypophysectomy and growth hormone treatment on sex-specific forms of cytochrome P-450 in relation to drug and steroid metabolisms in rat liver microsomes. Jpn J Pharmacol (1986) 0.79
A comparison of levels of glutathione transferases, cytochromes P450 and acetyltransferases in human livers. Biochem Pharmacol (1991) 0.79
Hormonal regulation of rat renal cytochrome P450s by androgen and the pituitary. Arch Biochem Biophys (1992) 0.79
DNA adducts formed by ring-oxidation of the carcinogen 2-naphthylamine with prostaglandin H synthase in vitro and in the dog urothelium in vivo. Carcinogenesis (1985) 0.79
Prediction of oral clearance from in vitro metabolic data using recombinant CYPs: comparison among well-stirred, parallel-tube, distributed and dispersion models. Xenobiotica (2005) 0.79
Partial purification and characterization of cytochrome P-450 responsible for the occurrence of sex difference in drug metabolism in the rat. Biochem Biophys Res Commun (1981) 0.79
Effect of growth hormone and ectopic transplantation of pituitary gland on sex-specific forms of cytochrome P-450 and testosterone and drug oxidations in rat liver. J Biochem (1986) 0.79
Dexamethasone and nitric oxide synthase gene expression in brain. J Psychiatry Neurosci (1997) 0.78
Induction of cytochrome P-450c and P-450d by metyrapone in the primary culture of rat hepatocytes. Jpn J Pharmacol (1989) 0.78
Metabolic activation of 2-amino-9H-pyrido[2,3-b]indole by rat-liver microsomes. Mutat Res (1982) 0.78
Effect of growth hormone on rat hepatic cytochrome P-450f mRNA: a new mode of regulation. Mol Cell Endocrinol (1990) 0.78
Molecular cloning and expression of an amine sulfotransferase cDNA: a new gene family of cytosolic sulfotransferases in mammals. J Biochem (1998) 0.78
Monomorphic and polymorphic isozymes of arylamine N-acetyltransferases in hamster liver: purification of the isozymes and genetic basis of N-acetylation polymorphism. Carcinogenesis (1990) 0.78
Fast-atom bombardment and electron-impact mass spectrometry of N-hydroxyarylamines, active intermediates of mutagenic aromatic amines. Xenobiotica (1985) 0.78
Metabolic activation of glutamic acid pyrolysis products, 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole and 2-amino-dipyrido[1,2-a:3',2'-d]imidazole, by purified cytochrome P-450. Chem Biol Interact (1981) 0.78
Covalent binding of N-hydroxy-Trp-P-2 to DNA by cytosolic proline-dependent system. Biochem Biophys Res Commun (1982) 0.78
A specific loss of growth hormone abolished sex-dependent expression of hepatic cytochrome P450 in dwarf rats: reversal of the profiles by growth hormone-treatment. Arch Biochem Biophys (1997) 0.78
Interactions between the active metabolite of tryptophan pyrolysate mutagen, N-hydroxy-Trp-P-2, and lipids: the role of lipid peroxides in the conversion of N-hydroxy-Trp-P-2 to non-reactive forms. Chem Biol Interact (1983) 0.77
Primary structure and molecular basis of polymorphic appearance of an acetyltransferase (AT-II)* in hamsters. Pharmacogenetics (1994) 0.77
Isolation and characterization of human liver cytochrome b5 cDNA. Pharmacol Res (1990) 0.77
Distinct effects of phenobarbital and its N-methylated derivative on liver cytochrome P450 induction. Arch Biochem Biophys (1996) 0.77
Acetyl coenzyme A dependent activation of N-hydroxy derivatives of carcinogenic arylamines: mechanism of activation, species difference, tissue distribution, and acetyl donor specificity. Cancer Res (1986) 0.77